A

Acusphere Inc
OTC:ACUS

Watchlist Manager
Acusphere Inc
OTC:ACUS
Watchlist
Price: 0.001 USD 900% Market Closed
Market Cap: 5 USD

Acusphere Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Acusphere Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
A
Acusphere Inc
OTC:ACUS
EPS (Diluted)
-$14
CAGR 3-Years
16%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
EPS (Diluted)
$10
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
7%
Bristol-Myers Squibb Co
NYSE:BMY
EPS (Diluted)
$2
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
EPS (Diluted)
$1
CAGR 3-Years
-31%
CAGR 5-Years
4%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
EPS (Diluted)
$7
CAGR 3-Years
8%
CAGR 5-Years
12%
CAGR 10-Years
7%
Eli Lilly and Co
NYSE:LLY
EPS (Diluted)
$20
CAGR 3-Years
45%
CAGR 5-Years
27%
CAGR 10-Years
25%
No Stocks Found

Acusphere Inc
Glance View

Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).

ACUS Intrinsic Value
Not Available

See Also

What is Acusphere Inc's EPS (Diluted)?
EPS (Diluted)
-14.6 USD

Based on the financial report for Dec 31, 2008, Acusphere Inc's EPS (Diluted) amounts to -14.6 USD.

What is Acusphere Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
26%

Over the last year, the EPS (Diluted) growth was -11%. The average annual EPS (Diluted) growth rates for Acusphere Inc have been 16% over the past three years , 26% over the past five years .

Back to Top